CFLAR and hepatocellular carcinoma: For example, it enhances TRAIL‐mediated apoptosis by upregulating DR5 through CHOP induction while suppressing c ‐ FLIP via miR‐708; these effects have been consistently demonstrated in multiple cancer cell lines (renal, lung, and hepatocellular carcinomas) [50].